.svg)
A clinical trial document management system controls the documents a trial generates and is inspected on — protocols, consent forms, regulatory submissions, monitoring reports, and the trial master file (TMF) — under GCP and 21 CFR Part 11, keeping every document current, version-controlled, access-restricted, and audit-trailed to withstand health-authority inspection.
The TMF is the evidentiary record that a trial was conducted properly; regulators inspect it, and gaps or version errors have serious consequences. A clinical trial DMS enforces the TMF structure, controls document status (draft, approved, effective, superseded), captures compliant electronic signatures, and maintains an immutable audit trail of every action — so "who approved this protocol amendment and when" is a query, not a scramble. Inspection readiness is continuous, not a pre-audit project.
Trials span sponsors, CROs, and sites across jurisdictions, so access control and data residency are central: each party sees only its permitted documents, and sensitive material may be subject to sovereignty rules about where it can reside. Systems must handle secure external collaboration (replacing email and shared drives), controlled distribution of protocol updates, and version integrity across every participating site simultaneously.
ioMoVo provides permission-controlled document management for clinical operations — audit-trailed, controlled workflows, immutable logging, electronic signatures, and secure multi-site collaboration — deployable on-premises or air-gapped where trial data cannot leave controlled infrastructure. See the ioMoVo life sciences page.
The trial master file — the complete set of documents proving a clinical trial was conducted according to protocol and regulation; it is the primary object of regulatory inspection.
The international quality standard for designing, conducting, and reporting clinical trials — it drives the document-control requirements a trial DMS must enforce.